Research and Markets (http://www.researchandmarkets.com/research/mfx9cr/global) has announced the addition of the "2013 Report on the International Cardiovascular Drugs Market - Forecasts to 2016" report to their offering.
In the last few years, the Healthcare industry has witnessed phenomenal growth in the APAC region. Emerging economies such as the APAC region, Eastern Europe, and Latin America hold vast growth potential. These regions are under-equipped to address the increase in the incidence of CVDs in the region. However, the increase in the incidence of CVDs and instances of patients frequently enduring long waits for therapeutic treatments are forcing healthcare organizations in the region to opt for cardiovascular drugs.
Moreover, there has been substantial investment to initiate a significant number of projects in R&D across the developing countries. Hence, healthcare organizations in developing regions such as the APAC region and the Middle East are opting for cardiovascular drugs in accordance with the demand in specific countries. The increasing demand for cardiovascular drugs in the developing countries is boosting the growth of the Global Cardiovascular Drugs market.
One of the major growth factors driving the Global Cardiovascular Drugs market is the increase in the prevalence of cardiovascular patients worldwide. Therapeutic drugs are among the remedies for CVDs, and hence healthcare organizations are opting for cardiovascular drugs for treatments.
Key Topics Covered:
1. Executive Summary
2. Introduction
3. Market Coverage
4. Market Landscape
5. Global Anti-hypertensive Drugs Market
6. Best Selling Anti-hypertensive Drugs
7. Global Anti-dyslipidemics Drugs Market
8. Best Selling Anti-dyslipidemic Drugs
9. Global Anti-thrombotics Drugs Market
10. Best Selling Anti-thrombotic Drugs
11. Drug Pipeline Analysis
12. Geographical Segmentation
13. Key Leading Countries
14. Rate of Incidence and Prevalence
15. Vendor Landscape
16. Buying Criteria
17. Market Challenges
18. Market Growth Drivers
19. Drivers and their Impact
20. Impact of Drivers and Challenges
21. Market Trends
22. Key Vendor Analysis
23. Other Reports in this Series
Companies Mentioned:
- Abbott Laboratories
- AstraZeneca
- Bayer
- Bristol-Myers Squibb
- Daiichi Sankyo
- F. Hoffmann-La Roche
- Forest Laboratories
- GlaxoSmithKline
- Merck & Co
- Novartis
- Pfizer
- Sanofi.
- Solvay SA
- Takeda Pharmaceutical
- The Medicines
For more information visit http://www.researchandmarkets.com/research/mfx9cr/global
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular
Devices